Recurrent Olfactory Neuroblastoma: A surgical Odyssey and the unexplored terrain of adjuvant therapies
Laryngo-Rhino-Otologie · 01.05.2024 · 103 (S 02 S 02) · S203
DOI: 10.1055/s-0044-1784656 ↗Kurz gefasst
Fachartikel in der Zeitschrift Laryngo-Rhino-Otologie, erschienen am 01.05.2024. Verfasst von Luis Bugia und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Olfactory neuroblastoma (ONB constitutes 3-6% of sinonasal tumors. Despite surgical approaches adjuvant and systemic targeted treatment options for advanced ONBs are rare.
Methods
We summarized the case history of female ONB patient with multiple relapses and lymph node metastases between 2009-2023.
Results
In july 2009 a female patient born 1963 presented with a endonasal mass. After histological confirmation of ONB, transnasal tumor resection occurred and was repeated twice due to local recurrence. Adjuvant radiotherapy (RT) was discontinued by the patient after a cumulative dose of 22 Gy. Over 10 years, multiple surgeries managed local recurrence and locoregional metastases, including combined intra- and extracranial resection, exenteratio orbitae, and various neck dissections. The patient continued to refuse adjuvant RT. In the search of therapeutical alternatives, whole exome sequencing (WES) and panel sequencing was performed in the frame of the molecular tumor board. While the WES did not reveal any molecular lesions with evidence level for a treatment recommendation, an amplification of CCND1 was identified in the panel. Subsequently, cdk4/6 inhibition with palbociclib off label was recommended in case of a surgically not manageable relapse. The patient refused this treatment as well and underwent two more tumor resections in the following years. From april 2023 best supportive care was indicated due to massive intracerebral progression. Shortly after, the patient died due to central respiratory failure.
Discussion
This case underscores ONB's high recurrence rate, emphasizing the crucial role of adjuvant RT in achieving long-term disease control as well as a chance for molecular tumor analysis in this rare tumor entity of the head and neck. Publication History Article published online: 19 April 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Bugia, L., Nowak, D., Rotter, N., & Affolter, A. (2024). Recurrent Olfactory Neuroblastoma: A surgical Odyssey and the unexplored terrain of adjuvant therapies. Laryngo-Rhino-Otologie, 103(S 02 S 02), S203. https://doi.org/10.1055/s-0044-1784656
Vancouver
Bugia L, Nowak D, Rotter N, Affolter A. Recurrent Olfactory Neuroblastoma: A surgical Odyssey and the unexplored terrain of adjuvant therapies. Laryngo-Rhino-Otologie. 2024;103(S 02 S 02):S203. doi:10.1055/s-0044-1784656
BibTeX
@article{Bugia2024,
author = {Bugia, Luis and Nowak, Daniel and Rotter, Nicole and Affolter, Annette},
title = {Recurrent Olfactory Neuroblastoma: A surgical Odyssey and the unexplored terrain of adjuvant therapies},
journal = {Laryngo-Rhino-Otologie},
year = {2024},
volume = {103},
number = {S 02 S 02},
pages = {S203},
doi = {10.1055/s-0044-1784656}
}
EUVIMED